High ROS levels can also promote tumor progression and aggressiveness by the activation of redox-sensitive nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and the master regulator of antioxidant response Nrf2 (see below), thus achieving resistance to drug therapies [40,41]. The gene discussed is NFE2L2; the disease is neoplasm.